Medications to reduce breast cancer risk: a network meta-analysis of randomized controlled trials

Abstract Background Given the rising incidence of breast cancer, especially in premenopausal women, there is an urgent need to identify additional risk-reducing medications to accelerate prevention, as only a few are currently approved. We, therefore, performed network meta-analysis (NMA) to identif...

Full description

Saved in:
Bibliographic Details
Main Authors: Ghazaleh Pourali, Minglu Liu, Supriya S. Sherpa, Angela Hardi, Chongliang Luo, Adetunji T. Toriola
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Breast Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13058-025-02059-w
Tags: Add Tag
No Tags, Be the first to tag this record!